Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

ATEC

Alphatec Holdings Inc

Feb 13 • 02:26PM ET

13.44

+0.34 2.60 %

Healthcare • Medical Devices • USA • NASD

Peers: SYK GMED ZBH SNN OFIX IART MEDP SIBN OSUR EOLS

| Held by: VTI IWM VXF IWO VTWO VHT SCHA IHI TMFG TMFM

Index	RUT	P/E	-	EPS (ttm)	-1.05	Insider Own	23.57%	Shs Outstand	147.54M	Perf Week	-2.75%
Market Cap	2.00B	Forward P/E	64.87	EPS next Y	0.21	Insider Trans	-12.21%	Shs Float	113.54M	Perf Month	-15.74%
Enterprise Value	2.46B	PEG	-	EPS next Q	0.04	Inst Own	74.56%	Short Float	12.79%	Perf Quarter	-35.23%
Income	-154.96M	P/S	2.74	EPS this Y	107.50%	Inst Trans	4.92%	Short Ratio	5.22	Perf Half Y	-13.68%
Sales	728.02M	P/B	172.33	EPS next Y	595.05%	ROA	-20.21%	Short Interest	14.52M	Perf YTD	-36.12%
Book/sh	0.08	P/C	12.82	EPS next 5Y	-	ROE	-540.40%	52W High	23.29 -42.29%	Perf Year	23.53%
Cash/sh	1.05	P/FCF	553.05	EPS past 3/5Y	8.90% -0.77%	ROIC	-27.91%	52W Low	8.81 52.55%	Perf 3Y	-1.75%
Dividend Est.	-	EV/EBITDA	261.78	Sales past 3/5Y	35.98% 40.07%	Gross Margin	58.35%	Volatility	6.11% 5.45%	Perf 5Y	-18.10%
Dividend TTM	-	EV/Sales	3.37	EPS Y/Y TTM	17.66%	Oper. Margin	-10.10%	ATR (14)	0.84	Perf 10Y	446.34%
Dividend Ex-Date	-	Quick Ratio	1.24	Sales Y/Y TTM	27.11%	Profit Margin	-21.29%	RSI (14)	31.09	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	31.62%	SMA20	-9.55%	Beta	1.03	Target Price	24.62
Payout	-	Debt/Eq	16.84	Sales Q/Q	30.38%	SMA50	-25.93%	Rel Volume	0.44	Prev Close	13.10
Employees	867	LT Debt/Eq	14.81	Earnings	Feb 24 AMC	SMA200	-12.58%	Avg Volume	2.78M	Price	13.44
IPO	Jun 02, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	195.54% 7.60%	Trades		Volume	938,485	Change	2.60%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-28-25	Resumed	Stifel	Buy	$20
Oct-24-25	Initiated	JP Morgan	Overweight	$19
Jun-16-25	Resumed	Lake Street	Buy	$18
Aug-01-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-08-24	Initiated	Barclays	Overweight	$19
Feb-09-24	Initiated	Wells Fargo	Overweight	$26
Dec-19-23	Reiterated	Needham	Buy	$16 → $18
Oct-20-23	Initiated	ROTH MKM	Buy	$22
Oct-12-22	Initiated	Jefferies	Buy	$12
Sep-12-22	Initiated	Morgan Stanley	Overweight	$13
Dec-03-21	Initiated	Goldman	Neutral	$12.50
Oct-29-21	Initiated	Loop Capital	Buy	$22
Aug-25-21	Initiated	Needham	Buy	$18
Aug-04-21	Resumed	Cowen	Outperform	$22.50
Mar-05-21	Reiterated	H.C. Wainwright	Buy	$16 → $19
Dec-21-20	Reiterated	H.C. Wainwright	Buy	$12 → $16
Oct-20-20	Initiated	Stifel	Buy	$13
Sep-03-20	Initiated	Cowen	Outperform	$12
Jun-18-20	Initiated	Northland Capital	Outperform	$9
Aug-28-19	Initiated	Canaccord Genuity	Buy	$7

Show Previous Ratings

Feb-12-26 05:30PM	Artivion (AORT) Q4 Earnings Surpass Estimates (Zacks)
Jan-30-26 12:24AM	TD Cowen Maintains Buy Rating for Alphatec (ATEC) While Adjusting PT to $20 Following Coverage Transfer (Insider Monkey)
Jan-16-26 11:34AM	Alphatec (ATEC) Jumps 9.5% on Bargain-Hunting After 2-Month Low (Insider Monkey)
02:52AM	Alphatec (ATEC) Surges 9.5%: Is This an Indication of Further Gains? (Zacks)
Jan-15-26 11:35AM	Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook (Insider Monkey) +9.47%
01:17AM	Loading…
Jan-14-26 01:17AM	Alphatec Touts 2026 Growth Plan at JPMorgan Conference, Guides to $890M Revenue and $20M FCF (MarketBeat)
Jan-12-26 09:30AM	ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion (PR Newswire) -22.34%
09:05AM	ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook (Business Wire)
Dec-19-25 07:19PM	Cannae, NextDecade, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-11-25 09:17AM	Here Are Thursdays Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More (24/7 Wall St.)
09:17AM	Crypto Market 2026 Predictions: Which Coins Will 10x and Which Will Crash? (24/7 Wall St.)
Nov-07-25 09:05AM	ATEC Mourns Passing of Board Member Jeffrey P. Rydin (Business Wire)
Nov-04-25 08:14PM	Alphatec Holdings Inc (ATEC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
03:56PM	Are Options Traders Betting on a Big Move in Alphatec Stock? (Zacks)
Nov-01-25 02:50PM	Alphatec (ATEC) Reaches New High on Strong Q3, Upbeat Outlook (Insider Monkey)
05:40PM	Loading…
Oct-30-25 05:40PM	Alphatec (ATEC) Q3 Earnings and Revenues Surpass Estimates (Zacks) +16.29%
04:38PM	Alphatec: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance (Business Wire)
Oct-29-25 09:42AM	Alphatec Holdings Inc (ATEC) Q3 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Oct-16-25 04:10PM	ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025 (Business Wire)
Aug-08-25 09:05AM	ATEC to Participate in Upcoming Conferences (Business Wire)
Aug-03-25 12:41PM	Alphatec (ATEC) Soars 27% on Raised Growth Outlook (Insider Monkey)
Aug-01-25 05:02PM	Alphatec Holdings Inc (ATEC) Q2 2025 Earnings Call Highlights: Record EBITDA and Market ... (GuruFocus.com) +30.15% +7.99%
Jul-31-25 05:55PM	Alphatec (ATEC) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	Alphatec: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance (Business Wire)
Jul-30-25 09:46AM	Alphatec Holdings Inc (ATEC) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-22-25 07:30AM	Buy Now or Regret Later: This Small-Cap Stock Has Big Disruption Potential (Barchart)
Jul-17-25 09:05AM	ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025 (Business Wire)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
02:57PM	Loading…
Jun-17-25 02:57PM	Why This Beaten Down Biotech Stock Might Be a Hidden Gem (Barchart)
01:34PM	Lake Street Capital Initiates Buy on Alphatec Holdings, Inc. (ATEC) with 63% Upside (Insider Monkey)
May-02-25 04:19PM	Paramount Global, Mid Penn Bancorp, and More Stocks See Action From Activist Investors (Barrons.com) +8.50%
03:16AM	Alphatec Holdings Inc (ATEC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-01-25 11:19PM	Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:05PM	Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:06PM	Alphatec: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance (Business Wire)
Apr-21-25 09:00AM	ATEC Launches PTP Corpectomy, The Next Evolution of Lateral Approach Surgery (Business Wire)
Apr-18-25 02:06PM	Six Flags, Rapid7, and More Stocks See Action From Activist Investors (Barrons.com)
Apr-15-25 03:12PM	Examination Of Alphatec Holdings: Prognosis--Chronic Cash Burn (Seeking Alpha)
Apr-14-25 09:00AM	ATEC to Report First Quarter 2025 Financial Results on May 1, 2025 (Business Wire)
Mar-28-25 12:00PM	abrdn Focused U.S. Small Cap Active ETF Q4 2024 Commentary (Seeking Alpha)
Mar-04-25 10:54PM	ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering (Business Wire)
Mar-03-25 04:00PM	ATEC Announces Proposed Convertible Senior Notes Offering (Business Wire)
Feb-27-25 07:10AM	Q4 2024 Alphatec Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +9.58%
02:21AM	Alphatec Holdings Inc (ATEC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-26-25 05:10PM	Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:17PM	Alphatec: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	ATEC Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-25-25 10:30AM	What To Expect From Alphatec Holdings Inc (ATEC) Q4 2024 Earnings (GuruFocus.com)
Feb-24-25 09:00AM	ATEC to Participate in Upcoming Conferences (Business Wire)
Feb-14-25 05:08PM	Southwest Airlines, Universal Technical, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-14-25 06:11AM	Alphatec (ATEC) Moves 9.1% Higher: Will This Strength Last? (Zacks)
Jan-13-25 09:00AM	ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook (Business Wire) +9.13%
Dec-11-24 09:00AM	Paragon 28 Appoints Dave Demski to Board of Directors (Business Wire)
Dec-09-24 09:00AM	ATEC to Present at the 2025 J.P. Morgan Healthcare Conference (Business Wire)
Dec-02-24 10:15AM	Alphatec Holdings (ATEC) Slid on Higher Than Expected Cash Burn Guidance (Insider Monkey)
Nov-20-24 04:40AM	Alphatec price target raised to $20 from $19 at Barclays (TipRanks)
Nov-04-24 09:00AM	ATEC to Participate in Upcoming Conferences (Business Wire)
Oct-31-24 03:20AM	Alphatec Holdings Inc (ATEC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +39.68%
Oct-30-24 05:10PM	Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Alphatec: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance (Business Wire)
Oct-07-24 09:00AM	ATEC to Report Third Quarter Financial Results on October 30, 2024 (Business Wire)
Sep-18-24 09:00AM	ATEC to Spotlight Clinically Integrated Informatics at NASS 2024 (Business Wire)
Aug-22-24 01:01AM	Insider Buying: Director David Demski Acquires Shares of Alphatec Holdings Inc (ATEC) (GuruFocus.com)
Aug-05-24 05:01PM	Director Keith Valentine Acquires 39,000 Shares of Alphatec Holdings Inc (ATEC) (GuruFocus.com)
05:01PM	Director David Demski Acquires 40,000 Shares of Alphatec Holdings Inc (ATEC) (GuruFocus.com)
Jul-31-24 05:15PM	Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -34.26%
04:09PM	Alphatec: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance (Business Wire)
Jul-29-24 09:00AM	ATEC to Present at Upcoming Conferences (Business Wire) -8.34%
Jul-24-24 09:00AM	ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI (Business Wire)
Jul-10-24 09:00AM	ATEC to Report Second Quarter Financial Results on July 31, 2024 (Business Wire)
Jun-10-24 09:00AM	Wake Up! 3 Lesser-Known Stocks Investors Are Sleeping On (InvestorPlace)
May-08-24 01:07PM	Alphatec Holdings, Inc. (NASDAQ:ATEC) Q1 2024 Earnings Call Transcript (Insider Monkey) -21.94%
May-07-24 09:56PM	ATEC Stock Earnings: Alphatec Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:00PM	Alphatec Holdings Inc (ATEC) Q1 2024 Earnings: Revenue Surpasses Estimates and Full-Year ... (GuruFocus.com)
04:43PM	Alphatec: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance (Business Wire)
May-02-24 09:00AM	ATEC to Present at Upcoming Conferences (Business Wire)
Apr-26-24 07:00PM	Alphatec Holdings Inc CFO John Koning Sells 37,500 Shares (GuruFocus.com)
04:41PM	Alphatec Holdings Insider Sold Shares Worth $480,750, According to a Recent SEC Filing (MT Newswires)
Apr-17-24 09:00AM	ATEC to Report First Quarter Financial Results on May 7, 2024 (Business Wire) -5.16%
Mar-10-24 03:24PM	3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio (InvestorPlace)
Mar-08-24 11:54PM	Director Quentin Blackford Acquires 20,000 Shares of Alphatec Holdings Inc (ATEC) (GuruFocus.com)
Mar-04-24 11:52PM	Alphatec Holdings Inc CFO John Koning Sells 121,601 Shares (GuruFocus.com)
Mar-01-24 12:40AM	Insider Sell: EVP of Sales David Sponsel Sells 32,365 Shares of Alphatec Holdings Inc (ATEC) (GuruFocus.com)
Feb-28-24 10:14AM	Alphatec Holdings, Inc. (NASDAQ:ATEC) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.87%
Feb-27-24 04:58PM	Alphatec Holdings Inc (ATEC) Reports Robust Revenue Growth and Margin Expansion in FY 2023 (GuruFocus.com)
04:52PM	Alphatec: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights (Business Wire)
Jan-29-24 09:00AM	ATEC to Present at Upcoming Conferences (Business Wire)
Jan-08-24 09:00AM	ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance (Business Wire) +9.10%
08:00AM	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan (GlobeNewswire)
Dec-19-23 09:00AM	ATEC to Present at the 2024 J.P. Morgan Healthcare Conference (Business Wire) +6.72%
Nov-07-23 10:52AM	Alphatec Holdings, Inc. (NASDAQ:ATEC) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.24%
Nov-06-23 04:43PM	Alphatec Holdings Inc (ATEC) Reports 32% Revenue Growth in Q3 2023, Raises Full Year EBITDA Guidance (GuruFocus.com)
04:39PM	Alphatec: Q3 Earnings Snapshot (Associated Press Finance)

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sponsel David	EVP, SALES	Feb 05 '26	Sale	13.79	60,425	833,261	349,500	Feb 06 06:57 PM
DAVID SPONSEL	Officer	Feb 05 '26	Proposed Sale	14.06	60,425	849,576		Feb 05 04:29 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Feb 03 '26	Sale	14.71	37,358	549,536	1,173,025	Feb 04 07:00 PM
Craig Hunsaker	officer	Feb 03 '26	Proposed Sale	14.67	37,358	548,196		Feb 03 01:01 PM
Miles Patrick	CEO	Jan 05 '26	Sale	21.01	100,000	2,101,000	5,135,398	Jan 06 07:00 PM
PATRICK MILES	Director	Jan 05 '26	Proposed Sale	20.76	300,000	6,228,000		Jan 05 04:43 PM
Lish Scott	CHIEF OPERATING OFFICER	Dec 16 '25	Sale	19.64	19,900	390,836	641,432	Dec 18 07:30 PM
Pelizzon David R	Director	Dec 16 '25	Sale	19.66	250,000	4,915,000	10,395,045	Dec 18 07:28 PM
SCOTT LISH	Officer	Dec 16 '25	Proposed Sale	19.71	19,900	392,229		Dec 16 04:28 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Dec 10 '25	Sale	20.84	32,584	679,051	1,256,558	Dec 12 07:18 PM
Sponsel David	EVP, SALES	Dec 10 '25	Sale	20.79	21,106	438,794	439,767	Dec 12 07:17 PM
Demski David M	Director	Dec 11 '25	Sale	21.20	30,000	636,000	399,623	Dec 12 07:14 PM
Demski David M	Director	Dec 11 '25	Proposed Sale	21.02	30,000	630,500		Dec 11 12:24 PM
Pelizzon David R	Director	Dec 08 '25	Sale	21.20	221,166	4,688,719	10,673,879	Dec 10 07:00 PM
Pelizzon David R	Director	Dec 09 '25	Sale	21.03	28,834	606,379	10,645,045	Dec 10 07:00 PM
Squadron Capital LLC	10% Owner	Dec 08 '25	Sale	21.20	221,166	4,688,719	10,673,879	Dec 10 07:00 PM
Squadron Capital LLC	10% Owner	Dec 09 '25	Sale	21.03	28,834	606,379	10,645,045	Dec 10 07:00 PM
Sponsel David	EVP, SALES	Dec 08 '25	Sale	21.45	988	21,193	460,873	Dec 10 07:00 PM
Squadron Capital Holdings LLC	10% Owner	Dec 08 '25	Sale	21.20	221,166	4,688,719	10,673,879	Dec 10 06:37 PM
Squadron Capital Holdings LLC	10% Owner	Dec 09 '25	Sale	21.03	28,834	606,379	10,645,045	Dec 10 06:37 PM
Pritzker Jennifer N.	10% Owner	Dec 08 '25	Sale	21.20	221,166	4,688,719	10,673,879	Dec 10 06:26 PM
Pritzker Jennifer N.	10% Owner	Dec 09 '25	Sale	21.03	28,834	606,379	10,645,045	Dec 10 06:26 PM
DAVID SPONSEL	Officer	Dec 10 '25	Proposed Sale	20.67	21,106	436,261		Dec 10 04:16 PM
Lish Scott	CHIEF OPERATING OFFICER	Dec 05 '25	Sale	21.47	10,875	233,486	661,332	Dec 09 07:00 PM
Marshall Tyson Eliot	GENERAL COUNSEL & CORP. SEC.	Dec 05 '25	Sale	21.47	22,889	491,526	345,442	Dec 09 07:00 PM
TYSON MARSHALL	Officer	Dec 05 '25	Proposed Sale	21.28	12,965	275,895		Dec 05 04:26 PM
TYSON MARSHALL	Officer	Dec 05 '25	Proposed Sale	21.49	9,924	213,272		Dec 05 04:15 PM
SCOTT LISH	Officer	Dec 05 '25	Proposed Sale	21.48	10,875	233,600		Dec 05 04:11 PM
Miles Patrick	CEO	Dec 01 '25	Sale	22.11	100,000	2,211,000	5,264,078	Dec 03 07:31 PM
Craig Hunsaker	officer	Dec 05 '25	Proposed Sale	198.70	32,584	6,474,444		Dec 01 12:26 PM
Pritzker Jennifer N.	10% Owner	Nov 24 '25	Sale	20.62	250,000	5,155,000	10,895,045	Nov 26 07:16 AM
Squadron Capital Holdings LLC	10% Owner	Nov 24 '25	Sale	20.62	250,000	5,155,000	10,895,045	Nov 26 07:16 AM
Pelizzon David R	Director	Nov 24 '25	Sale	20.62	250,000	5,155,000	10,895,045	Nov 25 07:00 PM
Squadron Capital LLC	10% Owner	Nov 24 '25	Sale	20.62	250,000	5,155,000	10,895,045	Nov 25 07:00 PM
Marshall Tyson Eliot	GENERAL COUNSEL & CORP. SEC.	Nov 20 '25	Sale	19.51	70,000	1,365,700	368,331	Nov 21 08:03 PM
Lish Scott	CHIEF OPERATING OFFICER	Nov 20 '25	Option Exercise	3.63	25,000	90,750	697,207	Nov 21 08:02 PM
Lish Scott	CHIEF OPERATING OFFICER	Nov 20 '25	Sale	19.80	25,000	495,000	672,207	Nov 21 08:02 PM
TYSON MARSHALL	Officer	Nov 20 '25	Proposed Sale	19.51	70,000	1,365,945		Nov 20 04:59 PM
SCOTT LISH	Officer	Nov 20 '25	Proposed Sale	19.80	25,000	494,948		Nov 20 04:23 PM
Squadron Capital Holdings LLC	10% Owner	Nov 12 '25	Sale	20.80	250,000	5,200,000	11,145,045	Nov 14 05:20 PM
Pritzker Jennifer N.	10% Owner	Nov 12 '25	Sale	20.80	250,000	5,200,000	11,145,045	Nov 14 05:12 PM
Pelizzon David R	Director	Nov 12 '25	Sale	20.80	250,000	5,200,000	11,145,045	Nov 14 04:36 PM
Squadron Capital LLC	10% Owner	Nov 12 '25	Sale	20.80	250,000	5,200,000	11,145,045	Nov 14 04:33 PM
Rydin Jeffrey P	Director	Nov 03 '25	Sale	19.32	200,000	3,864,000	385,441	Nov 05 06:30 PM
Miles Patrick	CEO	Nov 03 '25	Sale	18.96	100,000	1,896,000	5,364,078	Nov 05 06:30 PM
Rydin Jeffrey P	Director	Nov 03 '25	Proposed Sale	19.31	200,000	3,862,991		Nov 04 04:29 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Oct 31 '25	Sale	19.95	100,000	1,995,000	1,289,142	Oct 31 06:30 PM
Craig Hunsaker	officer	Oct 31 '25	Proposed Sale	19.91	100,000	1,991,000		Oct 31 05:33 PM
Sponsel David	EVP, SALES	Oct 24 '25	Sale	16.18	70,000	1,132,600	461,861	Oct 28 03:40 PM
DAVID SPONSEL	Officer	Oct 24 '25	Proposed Sale	15.89	70,000	1,112,300		Oct 24 04:27 PM
Lish Scott	CHIEF OPERATING OFFICER	Oct 14 '25	Option Exercise	3.35	13,500	45,225	672,207	Oct 15 07:20 PM
Miles Patrick	CEO	Oct 01 '25	Sale	13.96	100,000	1,396,000	5,464,078	Oct 03 07:00 PM
PATRICK MILES	Director	Oct 01 '25	Proposed Sale	14.54	300,000	4,362,000		Oct 01 04:34 PM
Sponsel David	EVP, SALES	Sep 18 '25	Sale	15.09	137,445	2,074,045	534,416	Sep 19 08:08 PM
Sponsel David	EVP, SALES	Sep 19 '25	Sale	15.34	2,555	39,194	531,861	Sep 19 08:08 PM
DAVID SPONSEL	Officer	Sep 19 '25	Proposed Sale	15.22	2,555	38,887		Sep 19 04:26 PM
DAVID SPONSEL	Officer	Sep 18 '25	Proposed Sale	14.70	137,445	2,020,442		Sep 18 04:28 PM
Berkowitz Mortimer III	Director	Sep 09 '25	Sale	15.97	62,500	998,125	618,050	Sep 11 07:30 PM
Miles Patrick	CEO	Sep 02 '25	Sale	15.73	300,000	4,719,000	5,564,078	Sep 04 07:00 PM
PATRICK MILES	Director	Sep 02 '25	Proposed Sale	15.90	300,000	4,770,000		Sep 02 04:39 PM
Lish Scott	CHIEF OPERATING OFFICER	Aug 21 '25	Sale	16.01	6,323	101,231	658,707	Aug 21 07:09 PM
Lish Scott	CHIEF OPERATING OFFICER	Aug 13 '25	Sale	16.00	9,302	148,832	665,030	Aug 15 05:42 PM
SCOTT LISH	Officer	Aug 13 '25	Proposed Sale	15.72	15,625	245,625		Aug 13 04:23 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Aug 05 '25	Sale	15.00	50,000	750,000	1,400,018	Aug 07 07:00 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Aug 06 '25	Sale	15.33	10,876	166,729	1,389,142	Aug 07 07:00 PM
TYSON MARSHALL	Officer	Aug 05 '25	Proposed Sale	14.91	18,092	269,689		Aug 05 05:23 PM
Lish Scott	CHIEF OPERATING OFFICER	Aug 01 '25	Sale	12.53	36,081	452,095	708,855	Aug 05 05:08 PM
Lish Scott	CHIEF OPERATING OFFICER	Aug 04 '25	Sale	14.00	17,857	249,998	690,998	Aug 05 05:08 PM
Lish Scott	CHIEF OPERATING OFFICER	Aug 05 '25	Sale	15.00	16,666	249,990	674,332	Aug 05 05:08 PM
Marshall Tyson Eliot	GENERAL COUNSEL & CORP. SEC.	Aug 05 '25	Sale	14.91	18,092	269,664	438,331	Aug 05 05:07 PM
Marshall Tyson Eliot	GENERAL COUNSEL & CORP. SEC.	Aug 01 '25	Sale	12.00	12,878	154,536	456,423	Aug 05 05:07 PM
SCOTT LISH	Officer	Aug 05 '25	Proposed Sale	14.87	16,666	247,823		Aug 05 05:06 PM
SCOTT LISH	Officer	Aug 04 '25	Proposed Sale	13.77	17,857	245,891		Aug 04 04:22 PM
SCOTT LISH	Officer	Aug 01 '25	Proposed Sale	10.58	19,230	203,453		Aug 01 04:31 PM
Marshall Tyson Eliot	GENERAL COUNSEL & CORP. SEC.	Jul 10 '25	Sale	12.00	1,500	18,000	469,301	Jul 14 06:00 PM
Lish Scott	CHIEF OPERATING OFFICER	Jul 10 '25	Sale	12.00	3,982	47,784	744,936	Jul 14 06:00 PM
SCOTT LISH	Officer	Jul 10 '25	Proposed Sale	11.49	20,833	239,371		Jul 10 04:34 PM
TYSON MARSHALL	Officer	Jul 10 '25	Proposed Sale	11.49	14,378	165,203		Jul 10 04:33 PM
Lish Scott	CHIEF OPERATING OFFICER	Jun 13 '25	Sale	11.07	22,727	251,588	748,918	Jun 17 06:00 PM
MCGINNIS KAREN K	Director	Jun 11 '25	Sale	12.11	3,963	47,992	68,709	Jun 13 05:30 PM
SCOTT LISH	Officer	Jun 13 '25	Proposed Sale	11.37	22,727	258,406		Jun 13 04:42 PM
MCGINNIS KAREN K	Director	Jun 11 '25	Proposed Sale	12.11	3,963	48,001		Jun 11 11:15 AM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Jun 04 '25	Sale	12.34	186,122	2,296,745	1,463,896	Jun 06 06:30 PM
Hunsaker Craig E	EVP, PEOPLE & CULTURE	Jun 05 '25	Sale	12.36	13,878	171,532	1,450,018	Jun 06 06:30 PM
Hunsaker Craig E	Officer	Jun 04 '25	Proposed Sale	12.00	350,000	4,200,000		Jun 03 04:29 PM
Lish Scott	CHIEF OPERATING OFFICER	May 19 '25	Sale	13.00	55,375	719,875	771,645	May 21 06:28 PM
Lish Scott	Officer	May 19 '25	Proposed Sale	13.00	55,375	719,902		May 19 04:50 PM
Lish Scott	CHIEF OPERATING OFFICER	May 05 '25	Sale	12.12	12,000	145,440	826,251	May 06 06:00 PM
Lish Scott	Officer	May 05 '25	Proposed Sale	11.75	12,000	141,000		May 05 05:20 PM
Koning John Todd	CHIEF FINANCIAL OFFICER	Apr 22 '25	Sale	10.71	37,500	401,625	466,536	Apr 23 06:48 PM
Koning John Todd	CHIEF FINANCIAL OFFICER	Mar 10 '25	Sale	9.72	165,121	1,604,976	483,107	Mar 12 05:00 PM
Lish Scott	CHIEF OPERATING OFFICER	Mar 10 '25	Sale	9.72	27,994	272,102	816,500	Mar 12 05:00 PM
JOHN TODD KONING	Officer	Mar 10 '25	Proposed Sale	10.46	202,621	2,119,416		Mar 10 04:24 PM
SCOTT LISH	Officer	Mar 10 '25	Proposed Sale	10.46	27,994	292,817		Mar 10 04:21 PM
Sponsel David	EVP, SALES	Mar 06 '25	Sale	10.83	33,732	365,318	668,977	Mar 10 03:01 PM
Miles Patrick	CEO	Mar 07 '25	Sale	10.64	12,691	135,032	5,857,603	Mar 07 08:33 PM
PATRICK MILES	Director	Mar 07 '25	Proposed Sale	10.80	12,691	137,063		Mar 07 04:19 PM
DAVID SPONSEL	Officer	Mar 06 '25	Proposed Sale	11.44	33,732	385,894		Mar 06 04:28 PM
MCGINNIS KAREN K	Director	Mar 03 '25	Sale	12.26	38,320	469,803	57,541	Mar 04 07:14 PM
MCGINNIS KAREN K	Director	Mar 03 '25	Proposed Sale	12.18	38,320	466,737		Mar 03 11:29 AM

Open in Screener

XGN

Exagen Inc

Feb 13 • 02:26PM ET

3.31

+0.07 2.19 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN ONC MYGN QGEN NTRA GH VCYT CDNA PRPO FLGT

| Held by: VTI VXF IWC ROSC DFAS DFAC DFSU DCOR

Index	-	P/E	-	EPS (ttm)	-0.93	Insider Own	37.81%	Shs Outstand	22.51M	Perf Week	-5.67%
Market Cap	75.04M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-0.61%	Shs Float	14.09M	Perf Month	-34.95%
Enterprise Value	67.56M	PEG	-	EPS next Q	-0.20	Inst Own	46.02%	Short Float	4.16%	Perf Quarter	-65.47%
Income	-19.04M	P/S	1.18	EPS this Y	-7.66%	Inst Trans	1.95%	Short Ratio	1.24	Perf Half Y	-64.57%
Sales	63.60M	P/B	4.11	EPS next Y	42.25%	ROA	-35.78%	Short Interest	0.59M	Perf YTD	-45.54%
Book/sh	0.81	P/C	2.10	EPS next 5Y	34.68%	ROE	-122.81%	52W High	12.23 -72.93%	Perf Year	-22.46%
Cash/sh	1.57	P/FCF	-	EPS past 3/5Y	20.95% 19.20%	ROIC	-43.97%	52W Low	2.67 24.00%	Perf 3Y	29.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.83% 6.62%	Gross Margin	59.86%	Volatility	7.39% 8.44%	Perf 5Y	-81.81%
Dividend TTM	-	EV/Sales	1.06	EPS Y/Y TTM	1.34%	Oper. Margin	-19.62%	ATR (14)	0.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.81	Sales Y/Y TTM	14.08%	Profit Margin	-29.94%	RSI (14)	25.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.08	EPS Q/Q	-12.16%	SMA20	-15.86%	Beta	1.90	Target Price	13.29
Payout	-	Debt/Eq	1.55	Sales Q/Q	37.87%	SMA50	-38.73%	Rel Volume	0.38	Prev Close	3.24
Employees	209	LT Debt/Eq	1.39	Earnings	Nov 04 BMO	SMA200	-57.72%	Avg Volume	472.28K	Price	3.31
IPO	Sep 19, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-97.58% 2.14%	Trades		Volume	137,858	Change	2.19%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-11-25	Initiated	B. Riley Securities	Buy	$15
Jul-30-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$12
Jul-23-25	Initiated	Craig Hallum	Buy	$12
Aug-05-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-15-21	Resumed	Cowen	Outperform	$26
Apr-15-21	Initiated	Canaccord Genuity	Buy	$25
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$32
Oct-08-20	Initiated	BTIG Research	Buy	$18
Jun-02-20	Resumed	Cantor Fitzgerald	Overweight	$19 → $20
Oct-14-19	Initiated	William Blair	Outperform
Oct-14-19	Initiated	Cowen	Outperform	$17
Oct-14-19	Initiated	Cantor Fitzgerald	Overweight	$18

Show Previous Ratings

Jan-11-26 03:00PM	Exagen Inc. Announces Select Preliminary 2025 Financial Results (GlobeNewswire)
Nov-11-25 09:00AM	Exagen Inc. to Participate in Fourth Quarter Investor Conferences (GlobeNewswire)
Nov-04-25 04:08PM	Exagen Inc (XGN) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion ... (GuruFocus.com) -8.96%
09:10AM	Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong Q3 2025 Results (GlobeNewswire)
08:06AM	Loading…
Nov-03-25 08:06AM	What To Expect From Exagen Inc (XGN) Q3 2025 Earnings (GuruFocus.com)
Oct-23-25 09:15AM	Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence (GlobeNewswire)
Oct-21-25 04:05PM	Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire)
Aug-12-25 10:30PM	[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-06-25 04:05PM	Exagen Inc. to Participate in Third Quarter Investor Conferences (GlobeNewswire)
Jul-29-25 09:10AM	Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates (Zacks) +14.34%
08:00AM	Exagen Inc. Reports Strong Q2 2025 Results (GlobeNewswire)
Jul-28-25 09:39AM	Exagen Inc (XGN) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-24-25 09:09AM	Exagen Inc. (XGN): A Bull Case Theory (Insider Monkey)
08:45AM	Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock? (Zacks)
04:05PM	Loading…
Jul-17-25 04:05PM	Exagen Inc. Appoints Chas McKhann to Board of Directors (GlobeNewswire)
Jul-15-25 04:05PM	Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 (GlobeNewswire)
Jun-23-25 09:00AM	Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics (GlobeNewswire)
May-09-25 04:05PM	Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares (GlobeNewswire) -7.31%
May-08-25 08:30AM	Exagen Inc. Prices Public Offering of Common Stock (GlobeNewswire) -9.81%
May-07-25 04:05PM	Exagen Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire) +6.39%
May-06-25 03:03AM	Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ... (GuruFocus.com)
01:18AM	Q1 2025 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
May-05-25 04:51PM	Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
09:10AM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume (GlobeNewswire)
May-02-25 09:36AM	Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-28-25 09:00AM	Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire) +7.09%
Apr-26-25 03:31AM	Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability (Seeking Alpha)
Apr-21-25 04:05PM	Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 (GlobeNewswire) +9.26%
03:04AM	Loading…
Mar-12-25 03:04AM	Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives (GuruFocus.com)
12:10AM	Q4 2024 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-11-25 09:15AM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +18.25%
08:00AM	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights (GlobeNewswire)
Feb-25-25 04:05PM	Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 (GlobeNewswire)
Feb-05-25 06:38AM	Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength? (Zacks) +6.18%
Feb-04-25 04:05PM	Exagen Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire) +29.38%
Jan-12-25 12:00PM	Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results (GlobeNewswire)
Dec-12-24 09:00AM	Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE CTD (GlobeNewswire) +12.02%
Nov-14-24 04:30PM	Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform (GlobeNewswire) +5.45%
Nov-13-24 04:05PM	Exagen Inc. to Participate in Fourth Quarter Investor Conferences (GlobeNewswire)
02:09AM	Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com)
12:51AM	Q3 2024 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-12-24 09:25AM	Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -6.06%
Nov-11-24 07:25AM	Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-24 04:05PM	Exagen to Announce Third Quarter 2024 Results on November 12, 2024 (GlobeNewswire)
Oct-21-24 04:05PM	Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence (GlobeNewswire)
Sep-04-24 04:05PM	Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference (GlobeNewswire) +15.93%
Aug-29-24 09:55AM	Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now (Zacks)
Aug-26-24 08:50AM	Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Aug-09-24 09:15AM	Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out? (Zacks) +22.46%
Aug-08-24 08:50AM	Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain (Zacks) +12.65%
Aug-05-24 12:53PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +17.65%
09:10AM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance (GlobeNewswire)
Aug-02-24 09:00AM	Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Aug-01-24 09:00AM	Exagen Appoints Jeffrey G. Black as New Chief Financial Officer (GlobeNewswire)
Jul-22-24 09:00AM	Exagen to Announce Second Quarter 2024 Results on August 5, 2024 (GlobeNewswire)
Jun-13-24 08:50AM	Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors (Zacks)
May-15-24 05:01AM	Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ... (GuruFocus.com) +8.52%
May-13-24 12:53PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:10AM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year (GlobeNewswire)
May-06-24 04:05PM	Exagen Announces Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-30-24 04:05PM	Exagen to Announce First Quarter 2024 Results on May 13, 2024 (GlobeNewswire)
Apr-26-24 08:30AM	Exagen Inc. Announces Changes to the Board of Directors (GlobeNewswire)
Mar-19-24 09:37AM	Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript (Insider Monkey) -12.99%
01:55AM	Q4 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-18-24 12:52PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +9.26%
09:25AM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Mar-08-24 09:00AM	Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (GlobeNewswire)
Mar-07-24 04:05PM	Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024 (GlobeNewswire)
Feb-06-24 08:50AM	Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock (Zacks)
Jan-30-24 04:05PM	Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -6.52%
Jan-07-24 12:00PM	Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance (GlobeNewswire)
Nov-13-23 04:05PM	Exagen Inc. Reports Strong Third Quarter 2023 Results (GlobeNewswire) +16.44%
Nov-09-23 04:05PM	Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers (GlobeNewswire) -6.25%
Nov-02-23 04:05PM	Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Oct-30-23 04:05PM	Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire) +6.75% +6.08%
Sep-28-23 04:05PM	Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting (GlobeNewswire)
Sep-12-23 04:05PM	Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-09-23 10:47AM	Exagen Inc. (NASDAQ:XGN) Q2 2023 Earnings Call Transcript (Insider Monkey) -7.22%
Aug-08-23 04:13AM	Q2 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 09:15AM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.76%
08:00AM	Exagen Inc. Reports Strong Second Quarter 2023 Results (GlobeNewswire)
Jul-26-23 04:05PM	Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-25-23 04:05PM	Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.51%
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
07:33AM	This Exagen Insider Increased Their Holding In The Last Year (Simply Wall St.)
Jun-13-23 08:19AM	Exagen Inc.'s (NASDAQ:XGN) Low P/S No Reason For Excitement (Simply Wall St.) -8.36%
May-30-23 09:00AM	Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
May-17-23 07:11AM	Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three years (Simply Wall St.) -6.90%
May-16-23 11:03AM	Q1 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents) +19.51%
May-15-23 05:55PM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports First Quarter 2023 Results (GlobeNewswire)
May-01-23 04:05PM	Exagen Announces Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-24-23 04:05PM	Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Mar-24-23 08:16AM	Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 06:12AM	Exagen Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ABALLI JOHN	President and CEO	Oct 16 '25	Sale	11.82	31,787	375,598	714,427	Oct 20 05:20 PM
Black Jeffrey G.	Chief Financial Officer	Sep 02 '25	Sale	9.79	20,466	200,362	269,026	Sep 04 07:40 PM
NMSIC Co-Investment Fund, L.P.	10% Owner	Mar 25 '25	Sale	3.30	350,000	1,155,000	1,758,958	Mar 27 04:15 PM

ATEC

Alphatec Holdings Inc

XGN

Exagen Inc

Upgrade your FINVIZ experience